ST Pharm Co.,Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported negative sales was KRW 0.00003 million compared to sales of KRW 0.00005 million a year ago. Net income was KRW 18,000.02 million compared to KRW 3,312.12 million a year ago.

Basic earnings per share from continuing operations was KRW 957 compared to KRW 177 a year ago. Diluted earnings per share from continuing operations was KRW 957 compared to KRW 177 a year ago. Basic earnings per share was KRW 957 compared to KRW 177 a year ago.